Markets:

Overview

News

Currencies

International

Treasuries

Castle Biosciences, Inc. - Common stock (NQ:CSTL)

39.58 -0.08 (-0.20%)

Streaming Delayed Price Updated: 1:46 PM EST, Dec 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Castle Biosciences, Inc. - Common stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Castle Biosciences to Release Second Quarter 2023 Financial Results and Host Conference Call on Wednesday, Aug. 2

July 19, 2023

From Castle Biosciences Inc.

Via Business Wire

Castle Biosciences to Host Second Annual Castle Cares Charity Walk

July 18, 2023

From Castle Biosciences, Inc.

Via Business Wire

Castle Biosciences Honored as an Arizona Top Workplace for the Second Consecutive Year

July 17, 2023

From Castle Biosciences Inc.

Via Business Wire

Why Shares of Castle Biosciences Fell This Week ↗

July 13, 2023

Reactions to insider selling by two key leaders sent the stock down for a fourth consecutive day.

Via The Motley Fool

Analyst Expectations for Castle Biosciences's Future ↗

July 07, 2023

Via Benzinga

Why Castle Biosciences Stock Is Crushing It Today ↗

July 07, 2023

The company received some unexpected good news.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Is Investigating Castle, Coinbase, Arrival, and BeiGene and Encourages Investors to Contact the Firm

July 16, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 12, 2023

Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.

Via Benzinga

Castle Biosciences Inc. (NASDAQ: CSTL) Leading the Way in Friday Trading Based on Percentage Gain

July 07, 2023

Via Investor Brand Network

BTIG Maintains Buy Rating for Castle Biosciences: Here's What You Need To Know ↗

June 15, 2023

Via Benzinga

Future Revenue Growth and Margin Expansion at Castle Biosciences Unrecognized, This Analyst Says ↗

June 06, 2023

Via Benzinga

Bragar Eagel & Squire, P.C. Is Investigating Advance Auto Parts, EPAM, and Castle and Encourages Investors to Contact the Firm

July 10, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 10, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

July 07, 2023

Via Benzinga

Why iMedia Brands Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

July 07, 2023

Gainers Prestige Wealth Inc. (NASDAQ: PWM) shares jumped 65.6% to $8.28. Prestige Wealth reported pricing of $5 million initial public offering of 1 million shares of common stock at a price of $5 per...

Via Benzinga

Alibaba, Kura Sushi USA And Other Big Stocks Moving Higher On Friday ↗

July 07, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Dow Drops 75 Points; US Economy Adds 209,000 Jobs In June ↗

July 07, 2023

U.S. stocks traded mostly lower this morning, with the Dow Jones dropping around 75 points on Friday. Following the market opening Friday, the Dow traded down 0.22% to 33,847.30 while the NASDAQ fell...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

July 07, 2023

Via Benzinga

Castle Biosciences to Present New DecisionDx®-SCC and DecisionDx®-Melanoma Data at the American Head & Neck Society’s (AHNS) 11th International Conference on Head and Neck Cancer

July 07, 2023

From Castle Biosciences Inc.

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Advance Auto Parts, EPAM, and Castle Biosciences and Encourages Investors to Contact the Firm

July 05, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Is Investigating EPAM, Castle, BeiGene and Fox and Encourages Investors to Contact the Firm

June 30, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Study Data from Castle Biosciences’ Collaboration with the National Cancer Institute’s SEER Program Registries Published in JCO Precision Oncology

June 30, 2023

From Castle Biosciences Inc.

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Comerica, Advance Auto Parts, EPAM, and Castle and Encourages Investors to Contact the Firm

June 25, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

June 20, 2023

From Castle Biosciences Inc.

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Texas Capital, EPAM, and Castle and Encourages Investors to Contact the Firm

June 19, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Kirby McInerney LLP Continues Investigation of Shareholder Claims Against Castle BioSciences, Inc. (CSTL)

June 16, 2023

From Kirby McInerney LLP

Via Business Wire

CASTLE ALERT: Bragar Eagel & Squire, P.C. is Investigating Castle Biosciences, Inc. on Behalf of Castle Stockholders and Encourages Investors to Contact the Firm

June 15, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Castle Biosciences Presents New Data Demonstrating the Ability of DecisionDx®-SCC to Identify Tumors Likely to Metastasize in Patients with Cutaneous Squamous Cell Carcinoma Deemed Low Risk by Traditional Staging

June 12, 2023

From Castle Biosciences Inc.

Via Business Wire

Kirby McInerney LLP Announces an Investigation of Shareholder Claims Against Castle Biosciences, Inc. (CSTL)

June 09, 2023

From Kirby McInerney LLP

Via Business Wire

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 06, 2023

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Castle Biosciences, Inc. - Common stock (NQ:CSTL)

All News about Castle Biosciences, Inc. - Common stock

Starting at $3.75/week.

Subscribe Today